Publications by authors named "Robbie Carson"

Claim this Profile
A
A phase Ia study of the MEK1/2 inhibitor PD-0325901 with the c-MET inhibitor crizotinib in patients with advanced solid cancers.
Peter Gallagher, Christian Rolfo, Elena Elez, Julien Taieb, Jennifer Houlden, Robbie Carson

BJC Rep· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ruthenium Drug BOLD-100 Regulates BRAFMT Colorectal Cancer Cell Apoptosis through AhR/ROS/ATR Signaling Axis Modulation.
Daryl Griffin, Robbie Carson, Debbie Moss, Tamas Sessler, Deborah Lavin

Mol Cancer Res· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting nucleotide metabolism enhances the efficacy of anthracyclines and anti-metabolites in triple-negative breast cancer.
Craig Davison, Roisin Morelli, Catherine Knowlson, Melanie McKechnie, Robbie Carson

NPJ Breast Cancer· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HDAC Inhibition Overcomes Acute Resistance to MEK Inhibition in BRAF-Mutant Colorectal Cancer by Downregulation of c-FLIPL.
Robbie Carson, Basak Celtikci, Cathy Fenning, Arman Javadi, Nyree Crawford

Clin Cancer Res· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ADAM17-dependent c-MET-STAT3 signaling mediates resistance to MEK inhibitors in KRAS mutant colorectal cancer.
Sandra Van Schaeybroeck, Murugan Kalimutho, Philip D Dunne, Robbie Carson, Wendy Allen

Cell Rep· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis